Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).
about
Lumbar sympathectomy techniques for critical lower limb ischaemia due to non-reconstructable peripheral arterial diseaseAngioplasty versus stenting for iliac artery lesionsAngioplasty versus bare metal stenting for superficial femoral artery lesionsScreening for peripheral arterial diseasePropionyl-L-carnitine for intermittent claudicationDisease management interventions for improving self-management in lower-limb peripheral arterial diseaseNaftidrofuryl for intermittent claudicationScreening for peripheral arterial diseaseAntiplatelet agents for intermittent claudicationAngioplasty versus stenting for superficial femoral artery lesionsPrimary stenting versus balloon angioplasty for stenotic and occlusive lesions of the iliac arteryNaftidrofuryl for intermittent claudicationManagement of lower extremity peripheral arterial diseaseRetrospective angiographic study to determine the effect of atherosclerotic stenoses of upstream arteries on the degree of atherosclerosis in distal vascular territoriesThe Completeness of Intervention Descriptions in Randomised Trials of Supervised Exercise Training in Peripheral Arterial DiseaseComparing Supervised Exercise Therapy to Invasive Measures in the Management of Symptomatic Peripheral Arterial DiseaseCell Therapy in Patients with Critical Limb IschemiaComparative Efficacy and Safety of Different Antiplatelet Agents for Prevention of Major Cardiovascular Events and Leg Amputations in Patients with Peripheral Arterial Disease: A Systematic Review and Network Meta-AnalysisKorean Guidelines for Interventional Recanalization of Lower Extremity ArteriesPeripheral artery disease and non-coronary atherosclerosis in Hispanics: another paradox?Critical limb ischemia: advanced medical therapyThe role of atherectomy in the treatment of lower extremity peripheral artery diseaseImaging of small animal peripheral artery disease models: recent advancements and translational potentialPlatelet-reactivity tests identify patients at risk of secondary cardiovascular events: a systematic review and meta-analysisAutologous immuno magnetically selected CD133+ stem cells in the treatment of no-option critical limb ischemia: clinical and contrast enhanced ultrasound assessed results in eight patients.2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice GuPulsed high-intensity-focused US and tissue plasminogen activator (TPA) versus TPA alone for thrombolysis of occluded bypass graft in swine.K-134, a phosphodiesterase 3 inhibitor, prevents brain damage by inhibiting thrombus formation in a rat cerebral infarction modelPeripheral artery disease: epidemiology and global perspectives.Computational drug repositioning for peripheral arterial disease: prediction of anti-inflammatory and pro-angiogenic therapeutics.Computational Network Model Prediction of Hemodynamic Alterations Due to Arteriolar Rarefaction and Estimation of Skeletal Muscle Perfusion in Peripheral Arterial Disease.The effectiveness of the paclitaxel-coated Luminor® balloon catheter versus an uncoated balloon catheter in superficial femoral and popliteal arteries in preventing vessel restenosis or reocclusion: study protocol for a randomized controlled trial.Serum Thyrotropin Concentrations Are Not Associated with the Ankle-Brachial Index: Results from Three Population-Based StudiesSafety and efficacy of patient specific intramuscular injection of HGF plasmid gene therapy on limb perfusion and wound healing in patients with ischemic lower extremity ulceration: results of the HGF-0205 trial.Adeno-associated virus serotype 9 efficiently targets ischemic skeletal muscle following systemic delivery.Peripheral arterial disease in diabetes: is there a role for genetics?Multimodality image fusion to guide peripheral artery chronic total arterial occlusion recanalization in a swine carotid artery occlusion model: unblinding the interventionalistData on amputation free survival of patients with lower limb peripheral artery disease classified according TASC II classification and a new crural index.Role of infrainguinal angioplasty in the treatment of critical limb ischaemia.Current state of endovascular treatment of femoro-popliteal artery disease.
P2860
Q24186303-53D544EF-34D5-416D-87FE-F6D1219E762CQ24187772-77DB235E-C8AA-4918-8091-4C0B56CB6BB2Q24193807-C78315BB-F91B-4758-A79E-98FE65690132Q24197484-56F32652-F059-44AE-9647-D0B6B08755DCQ24201080-E196DDD5-9ED8-4471-89B5-F8ED70F55534Q24201570-0D5FB762-71DB-44DA-BB2B-6A43CDA0D1B4Q24202499-6F533645-AA4E-432B-9D04-F9DAE70A35C8Q24202715-6880BD8F-0D99-47AE-878D-64932F74F73EQ24235178-AB7EBE35-B3D6-4CA9-9643-37E1C75090A9Q24241014-F9B00D60-4C62-488F-BF4E-C4EED644715BQ24242603-C6879D52-5A3A-4626-A91F-D955EABD2DC1Q24242960-2B14DB30-1967-45D9-9A8C-88CF9F3509D4Q24655017-77B9B4DA-6D09-4C1E-A0E3-667F37D95CB8Q24658531-7818AA0D-625B-411F-B3F3-B990EA02553BQ26764726-018731CC-52F9-4704-A0B1-F7605F36AC7EQ26776109-7B0462C2-66E7-40B3-BAEA-A752C444F6ACQ26795443-B1C1BBC1-78EF-4120-A25D-E20A291EC984Q26798134-C1062390-039F-40E9-99D7-3EBFF8A0B89DQ26801709-9FB93A1F-7453-4E5F-926C-03ECF4F8CF80Q26828001-3047B6BF-5284-4557-8264-EF172BDF0941Q26995245-3029132B-8DC9-40ED-A852-E01B15C84567Q27002637-1B80AB89-3323-40C9-9A27-A986F75C069DQ27009178-732FA214-FB7E-40CD-81F4-68AD547B9314Q27010236-80F034F8-F9DF-4B11-86C6-8E963FE65969Q27303621-D20A4A73-EC7A-48D6-BB06-9CF32C75E8F4Q28249469-E479966B-7692-434E-A695-8717FD5822D9Q28267010-9B298C5B-790F-4CCE-A6E5-FAB493EF9948Q28484521-323432CD-57BC-40C5-96D9-DC8D795D8129Q30241154-F17E038C-6D1A-4A50-A090-B8F387B0D0FDQ30278668-A8BAB0D0-DC22-4FC8-A419-6C6D79E14122Q30300196-2CA3274A-DC54-4859-8F66-4FBC1FD27F4DQ30313782-71498A5E-290D-44A5-97DB-769332F6811BQ30315945-9A6F2146-AC4B-489A-A2AE-DCD656B7716EQ30354271-81BC990D-E9E6-42F5-80F1-25AF9F14305DQ30414524-F5A5F154-108A-4D6E-B5A8-091AD895BBF6Q30426617-65314E26-6D05-4BAB-80F7-507E6DC28649Q30446503-E249F330-674D-4DE3-A2EC-43F76F14AC41Q31109821-3FA07B35-23B3-46D1-84CA-CBF9707532CFQ33282882-FD67EF1C-E98B-402B-9269-D985337A52E8Q33298566-72FC6267-A193-462D-84E4-30310F632DB2
P2860
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).
@ast
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).
@en
Inter-Society Consensus for the Management of Peripheral Arterial Disease
@nl
type
label
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).
@ast
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).
@en
Inter-Society Consensus for the Management of Peripheral Arterial Disease
@nl
prefLabel
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).
@ast
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).
@en
Inter-Society Consensus for the Management of Peripheral Arterial Disease
@nl
P2093
P1476
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).
@en
P2093
Christopher White
Christos Liapis
Denis Clement
Emile Mohler
F G R Fowkes
Henrik Sillesen
Hiroshi Shigematsu
Isabelle Durand-Zaleski
J A Dormandy
Johannes Lammer
P356
10.1016/J.EJVS.2006.09.024
P478
33 Suppl 1
P577
2006-11-29T00:00:00Z